Lin X, Jiang JD, Guo XZ, Hu KK. Dermatoscope for the diagnosis of erythema with purpura induced by lidocaine/prilocaine cream: A case report. World J Clin Cases 2024; 12(22): 5225-5228 [PMID: 39109011 DOI: 10.12998/wjcc.v12.i22.5225]
Corresponding Author of This Article
Xiu Lin, Doctor, MD, Doctor, Researcher, Department of Medical Aesthetics, Guangdong Women and Children Hospital, No. 521 Xingnan Avenue, Panyu District, Guangzhou 511400, Guangdong Province, China. 474319186@qq.com
Research Domain of This Article
Allergy
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Aug 6, 2024; 12(22): 5225-5228 Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5225
Dermatoscope for the diagnosis of erythema with purpura induced by lidocaine/prilocaine cream: A case report
Xiu Lin, Jin-Dou Jiang, Xue-Zhen Guo, Kui-Kui Hu
Xiu Lin, Jin-Dou Jiang, Xue-Zhen Guo, Kui-Kui Hu, Department of Medical Aesthetics, Guangdong Women and Children Hospital, Guangzhou 511400, Guangdong Province, China
Author contributions: Hu KK and Jiang JD reviewed and revised the manuscript; Guo took good care of the patient and reviewed the manuscript.
Supported byQingxin District Science and Technology Plan Project of Qingyuan, Guangdong Province, China, No. 2023QJ06012.
Informed consent statement: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent may be requested for review from the corresponding author.
Conflict-of-interest statement: All authors have no conflicts of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiu Lin, Doctor, MD, Doctor, Researcher, Department of Medical Aesthetics, Guangdong Women and Children Hospital, No. 521 Xingnan Avenue, Panyu District, Guangzhou 511400, Guangdong Province, China. 474319186@qq.com
Received: April 11, 2024 Revised: May 29, 2024 Accepted: June 19, 2024 Published online: August 6, 2024 Processing time: 81 Days and 24 Hours
Abstract
BACKGROUND
Lidocaine/prilocaine (EMLA) cream is a local anesthetic that is applied to the skin or mucosa during painful therapeutic procedures with few reported side effects.
CASE SUMMARY
Here, we report the use of dermatoscopy to identify a case of erythema with purpura, a rare side effect, after the application of 5% EMLA cream.
CONCLUSION
We conclude that erythema with purpura is caused by irritation and toxicity associated with EMLA, but the specific mechanism by which the toxic substance affects skin blood vessels is unclear. In response to this situation and for cosmetic needs, we recommend tranexamic acid, in addition to routine therapy, to prevent changes in pigmentation in patients with dermatitis.
Core Tip: We report erythema and purpura under dermatoscope induced by lidocaine/prilocaine (EMLA) in a female in the process of cosmetic dermatology. We analyzed the possible etiology and pathology of the dermatitis specifically. This is the first time to share this case report, of which the content has not been published, nor has submitted for publication elsewhere. We expect this report will draw more attention to the use of EMLA especially from dermatologist for cosmetic therapy.
